These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7867478)

  • 1. CEA content in breast lesions.
    Schmitt FC
    Diagn Cytopathol; 1994; 11(3):307-8. PubMed ID: 7867478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carcinoembryonic antigen in serum and tissue of benign and cancerous breast lesions].
    von Kleist S; Wittekind C; Polack M; Gropp H; Sandritter W
    Arch Geschwulstforsch; 1981; 51(6):523-6. PubMed ID: 6277268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
    Wittekind C; von Kleist S; Sandritter W
    Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevance of CEA in benign breast disease (author's transl)].
    Opri F; Kirchner H; Mayfeld K
    Geburtshilfe Frauenheilkd; 1980 Jan; 40(1):51-4. PubMed ID: 7353775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases.
    Alexiev BA; Valkov IN; Popov AA; Marinov VS
    Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carcinoembryogenic antigen (CEA) and lactoferrin (LF) in benign and malignant disease of the breast. A contribution to the immuno-histological demonstration of marker substances (author's transl)].
    Wurster K; Heberling D; Rapp W
    Geburtshilfe Frauenheilkd; 1980 May; 40(5):412-22. PubMed ID: 6250937
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
    Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
    Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
    [No Abstract]   [Full Text] [Related]  

  • 8. CEA and NCA in benign and malignant breast tumors.
    Nap M; Keuning H; Burtin P; Oosterhuis JW; Fleuren G
    Am J Clin Pathol; 1984 Nov; 82(5):526-34. PubMed ID: 6388310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.
    Schmitt FC; Andrade L
    J Clin Pathol; 1995 Jan; 48(1):53-6. PubMed ID: 7706519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
    Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
    Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer mucin: an automated assay to detect mucus glycoproteins.
    Bonfrer JM; de Graaf HM; Nooijen WJ
    Tumour Biol; 1992; 13(3):162-7. PubMed ID: 1626180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEA-like material in fluid from benign cysts of the breast.
    Fleisher M; Oettgen HF; Breed CN; Robbins GF; Pinsky CM; Schwartz MK
    Clin Chem; 1974; 20(1):41-2. PubMed ID: 4809471
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
    Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen and L-fucose in malignant and benign mammary disease.
    Wilkinson EJ; Hause LL; Sasse EA; Pattillo RA; Milbrath JR; Lewis JD
    Am J Clin Pathol; 1980 May; 73(5):669-75. PubMed ID: 7377133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma.
    Shousha S; Lyssiotis T
    Histopathology; 1978 Nov; 2(6):433-47. PubMed ID: 365699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoembryonic antigen (CEA) in breast cancer].
    Góźdź S; Słuszniak J; Bukowski J; Kowalski D; Zagała A; Urbania A; Gorazda-Postuła L; Korejba W; Banasińska E
    Nowotwory; 1985; 35(4):305-9. PubMed ID: 3831945
    [No Abstract]   [Full Text] [Related]  

  • 19. A correlation of erythrocyte sedimentation and plasma carcinoembryonic antigen in fibrocystic disease and carcinoma of the breast.
    Thynne GS; Greening WP
    Clin Oncol; 1980 Dec; 6(4):317-21. PubMed ID: 7460405
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.